A 32-year-old man from Delhi presents with a 3-day history of fever, productive cough, and pleuritic chest pain. Chest X-ray shows a right lower lobe infiltrate with a small pleural effusion. Blood culture and sputum culture both grow methicillin-resistant Staphylococcus aureus (MRSA). The patient has no prior hospitalisation and denies intravenous drug use. What is the most appropriate next step in management?

Explanation

## Clinical Context This is a case of community-acquired MRSA pneumonia with bacteraemia (positive blood culture). The patient has no risk factors for healthcare-associated MRSA (no prior hospitalisation, not an IVDU), yet MRSA has been isolated from both blood and sputum, indicating invasive disease. ## Management Algorithm ```mermaid flowchart TD A[MRSA bacteraemia + pneumonia confirmed]:::outcome --> B{Renal function normal?}:::decision B -->|Yes| C[Vancomycin 15-20 mg/kg IV Q8-12H]:::action B -->|No| D[Adjust dosing or use alternative]:::action C --> E[Obtain baseline creatinine & trough level]:::action E --> F[Target trough 15-20 mcg/mL]:::action F --> G[Repeat blood cultures at 48-72 hrs]:::action G --> H{Sterilisation achieved?}:::decision H -->|Yes| I[Continue vancomycin for 4 weeks]:::action H -->|No| J[Consider echocardiography for endocarditis]:::urgent ``` ## Why Vancomycin Is the Correct Choice **Key Point:** MRSA is resistant to all β-lactams (methicillin, cloxacillin, nafcillin). Vancomycin is the first-line agent for serious MRSA infections (bacteraemia, pneumonia, endocarditis). **High-Yield:** Vancomycin dosing for serious infections: - Loading: 15–20 mg/kg IV (based on actual body weight) - Maintenance: 15–20 mg/kg IV every 8–12 hours - Target trough: 15–20 mcg/mL (drawn just before the 4th or 5th dose) - Renal function must be checked before initiation and monitored weekly **Clinical Pearl:** Positive blood cultures in a patient with pneumonia raise concern for haematogenous spread. Echocardiography is indicated ONLY if: 1. Blood cultures remain positive after 48–72 hours of appropriate therapy (suggesting inadequate source control or endocarditis), OR 2. New cardiac murmur, embolic phenomena, or septic emboli are detected. Echocardiography is not a prerequisite before starting antibiotics in uncomplicated bacteraemic pneumonia; delaying therapy increases mortality risk. **Mnemonic: MRSA Therapy Hierarchy — "VILE"** - **V**ancomycin (first-line for serious MRSA) - **I**nfection source control (drainage, debridement if needed) - **L**inezolid (alternative if vancomycin intolerance or CNS penetration needed) - **E**chocardiography (only if clinical concern for endocarditis) ## Monitoring Requirements 1. Baseline creatinine, electrolytes, liver function 2. Vancomycin trough level (4th or 5th dose) 3. Repeat blood cultures at 48–72 hours to confirm sterilisation 4. Weekly renal function and vancomycin levels during therapy [cite:Harrison 21e Ch 139]